G protein-coupled receptors: Crystallizing how agonists bind

Comment

Man Tsuey Tse. Nat Rev Drug Discov. 2011 Feb.

. 2011 Feb;10(2):97.

doi: 10.1038/nrd3379.

No abstract available

Comment on

Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.
Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, Devree BT, Rosenbaum DM, Thian FS, Kobilka TS, Schnapp A, Konetzki I, Sunahara RK, Gellman SH, Pautsch A, Steyaert J, Weis WI, Kobilka BK. Rasmussen SG, et al. Nature. 2011 Jan 13;469(7329):175-80. doi: 10.1038/nature09648. Nature. 2011. PMID: 21228869 Free PMC article.
Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
Rosenbaum DM, Zhang C, Lyons JA, Holl R, Aragao D, Arlow DH, Rasmussen SG, Choi HJ, Devree BT, Sunahara RK, Chae PS, Gellman SH, Dror RO, Shaw DE, Weis WI, Caffrey M, Gmeiner P, Kobilka BK. Rosenbaum DM, et al. Nature. 2011 Jan 13;469(7329):236-40. doi: 10.1038/nature09665. Nature. 2011. PMID: 21228876 Free PMC article.
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
Warne T, Moukhametzianov R, Baker JG, Nehmé R, Edwards PC, Leslie AG, Schertler GF, Tate CG. Warne T, et al. Nature. 2011 Jan 13;469(7329):241-4. doi: 10.1038/nature09746. Nature. 2011. PMID: 21228877 Free PMC article.